A Phase 1/2 Study of the Oral RET Inhibitor LOXO-292in Pediatric Patients with Advanced RET-Altered Solid orPrimary Central Nervous System Tumors

Greengard, Emily G (PI)

Pediatric Hematology/Oncology

Project: Research project

Description

A Phase 1/2 Study of the Oral RET Inhibitor LOXO-292 in Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors

Status	Finished
Effective start/end date	5/15/20 → 5/31/25

Funding

LOXO ONCOLOGY